Hana Visnova
Overview
Explore the profile of Hana Visnova including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
105
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sanchez M, Visnova H, Larsson P, Andersen C, Filicori M, Blockeel C, et al.
Hum Reprod
. 2022 Apr;
37(6):1161-1174.
PMID: 35451013
Study Question: Does addition of choriogonadotropin beta (recombinant CG beta) to follitropin delta increase the number of good-quality blastocysts following ovarian stimulation in a long GnRH agonist protocol? Summary Answer:...
2.
Visnova H, Papaleo E, Martin F, Koziol K, Klein B, Mannaerts B
Reprod Biomed Online
. 2021 Nov;
43(6):1019-1026.
PMID: 34756645
Research Question: How does the efficacy and safety of individualized follitropin delta dosing compare with conventional dosing for ovarian stimulation in potential high responders? Design: Retrospective analysis of 153 potential...
3.
Hubka P, Visnova H, Sehnal B, Lincova M, Zikan M
Ceska Gynekol
. 2021 May;
86(2):124-127.
PMID: 34020560
Objective: To present current possibilities of the prevention and therapy of ovarian hyperstimulation syndrome (OHSS). Methods: Literature and guidelines were researched. Results: From the view of safety and prevention of...
4.
Bagocsi T, Rumpik D, Krenek O, Machac S, Vrublovsky P, Stepan J, et al.
Ceska Gynekol
. 2021 May;
86(2):86-92.
PMID: 34020554
Methods: Individualized follitropin delta daily dose in µg based on the patient’s anti-Müllerian hormone (AMH) level and body weight (AMH < 15 pmol/ L: 12 µg/ d; AMH > 15...
5.
Fernandez-Sanchez M, Visnova H, Yuzpe A, Klein B, Mannaerts B, Arce J
Reprod Biomed Online
. 2019 Feb;
38(4):528-537.
PMID: 30713022
Research Question: Is individualization of dosing with follitropin delta in sequential ovarian stimulation cycles an effective preventive strategy for ovarian hyperstimulation syndrome risk? If so, for which patients does an...
6.
Bosch E, Nyboe Andersen A, Barri P, Garcia-Velasco J, De Sutter P, Fernandez-Sanchez M, et al.
Clin Endocrinol (Oxf)
. 2015 Jul;
83(6):902-12.
PMID: 26202150
Objective: To study the association between serum anti-Müllerian hormone (AMH) levels and follicular development and endocrine responses induced by increasing doses (5·2-12·1 μg/day) of a novel recombinant human FSH (rhFSH,...
7.
Arce J, Nyboe Andersen A, Fernandez-Sanchez M, Visnova H, Bosch E, Garcia-Velasco J, et al.
Fertil Steril
. 2014 Sep;
102(6):1633-40.e5.
PMID: 25256937
Objective: To evaluate the dose-response relationship of a novel recombinant human FSH (rhFSH; FE 999049) with respect to ovarian response in patients undergoing IVF/intracytoplasmic sperm injection treatment; and prospectively study...